Charts Oramed Pharmaceuticals Inc. Deutsche Boerse AG
Stocks
OJU1
US68403P2039
Biotechnology & Medical Research
|
Market Closed -
Deutsche Boerse AG
02:00:45 2026-09-30 EDT
|
After hours 16:00:00 | |||
| 4.080 EUR | -0.97% |
|
4.118 | +0.93% |
| 09-20 | Oramed Pharmaceuticals Inc.(NasdaqCM:ORMP) added to S&P Global BMI Index | CI |
| 08-31 | Lifeward Names Josh Hexter as Interim CEO and Rami Aviram as CFO | MT |
Chart: Technical Analysis
Deutsche Boerse AGEUR
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| ORMP | Delayed | |
CBOE
| ORMP | Real-time | |
|
TEL AVIV STOCK EXCHANGE
| ORMP | Delayed | |
|
Deutsche Boerse AG
| OJU1 | Delayed | |
|
Tradegate
| OJU1 | Real-time | |
|
Börse Stuttgart
| OJU1 | Delayed | |
|
Boerse Muenchen
| OJU1 | Real-time |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- ORMP Stock
- OJU1 Stock
- Charts Oramed Pharmaceuticals Inc.
Select your edition
All financial news and data tailored to specific country editions
